About this trial

Participants included in this study will first swallow a patency capsule and then undergo an abdominal X-ray scan within 30 hours after swallowing the capsule to confirm weather the capsule is still in the body.

Eligibility criteria

Qualifiers

Patients with suspected or known intestinal stricture (with medical history records, physical examination records, and imaging evidence within the last 6 months.

Patients suffering from Crohn's Disease

Patients with long-term use of non-steroidal anti-inflammatory drugs.

Patients with abdominal symptoms related to intestinal stricture.

Disqualifiers

Patients with esophageal obstruction or swallowing disorder diseases.

Patients who are ineligible for surgery or refuse to undergo any abdominal surgery.

Patients with known allergies or other contraindications or intolerance to the medications used in this study.

Patients with pacemakers or other implanted electronic devices such as cochlear implants, magnetic metal drug infusion pumps, neurostimulators.

Trial design

Treatments tested in this trial

  • NaviCam Patency Capsule

Treatment groups

25 Participants
are divided into 1 treatment group

Locations

1
Digestive Health Services60515, Downers GroveIllinois, United States

Sponsors and collaborators

AnX Robotica Corp.

Lead sponsor